Is It Too Late To Consider Buying Agilent Technologies, Inc. (NYSE:A)? [Yahoo! Finance]
Wasatch BioLabs Announces Co-Marketing Agreement With Agilent to Advance Native-Read Targeted Sequencing [Yahoo! Finance]
Biopharmaceutical Process Analytical Technology Market to Surge: $3.49 Billion by 2030 Predicts Report [Yahoo! Finance]
Agilent to Present at the 44th Annual J.P. Morgan Healthcare Conference
Agilent Technologies (NYSE:A) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $165.00 price target on the stock.